In conclusion, we demonstrate that preventing local expression of CD9 by PEC in glomeruli alleviates glomerular damages in two distinct severe diseases, CGN and FSGS (Supplementary Fig. 17). This evidence concerns the gene CD9 and focal segmental glomerulosclerosis.